EW vs MD · P/E 47, rev $1.39B vs P/E 11, $1.93B cap
Edwards Lifesciences Corp (EW) versus Mednax Inc (MD) — a side-by-side from cached financials, not a winner call.
Edwards Lifesciences Corp (EW) is a medical devices company listed on NYSE.
Mednax Inc (MD) is a medical care facilities company listed on NYSE.
Latest reported EW revenue for 2024-12-31 was $1.39B. Net income was $385.6M. Revenue was up 2.3% from 2024-09-30 to 2024-12-31. EW currently screens at market cap $49.91B and trailing P/E 46.9.
MD does not have a complete income-statement cache yet.
EW currently screens at market cap $49.91B and trailing P/E 46.9. MD currently screens at market cap $1.93B and trailing P/E 11.4.
Not investment advice. Open the EW and MD stock pages for the full models.
Not investment advice.